Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $51.6 Million - $69.8 Million
-604,300 Reduced 45.81%
714,900 $76.2 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $40 Million - $60.1 Million
575,200 Added 77.31%
1,319,200 $131 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $40.5 Million - $53.2 Million
420,500 Added 129.98%
744,000 $76.8 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $25.5 Million - $34.6 Million
215,400 Added 199.26%
323,500 $39.3 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $22.4 Million - $32.5 Million
-165,100 Reduced 60.43%
108,100 $16.6 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $20.7 Million - $36.8 Million
-175,100 Reduced 39.06%
273,200 $49.1 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $5.04 Million - $8.29 Million
42,700 Added 10.53%
448,300 $53 Billion
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $3.8 Million - $5.72 Million
-32,400 Reduced 7.4%
405,600 $57.9 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $8.13 Million - $15.1 Million
-64,300 Reduced 12.8%
438,000 $75.4 Million
Q4 2021

Feb 10, 2022

SELL
$225.82 - $368.51 $4.27 Million - $6.96 Million
-18,900 Reduced 3.63%
502,300 $128 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $4.77 Million - $10.4 Million
21,500 Added 4.3%
521,200 $201 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $29.9 Million - $54.1 Million
230,100 Added 85.35%
499,700 $117 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $29.4 Million - $50.1 Million
269,600 New
269,600 $35.3 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.